NCT05514132 2026-03-09
A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Active not recruiting
Clinical Trials
24 trialsNCT06795412 2026-03-06
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
Pyxis Oncology, Inc
Phase 1/2 Recruiting
NCT02617277 2026-03-04
Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT06929260 2026-01-22
A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z
AstraZeneca
Phase 1 Terminated
NCT05508334 2025-12-22
A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
RemeGen Co., Ltd.
Phase 1/2 Completed
NCT06868199 2025-09-12
A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours
LaNova Medicines Limited
Phase 1/2 Recruiting
NCT06927349 2025-04-15
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.
Shandong Boan Biotechnology Co., Ltd
Phase 1 Recruiting
NCT03421353 2024-08-21
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
AstraZeneca
Phase 1 Completed
NCT05804526 2024-04-30
A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours
RemeGen Co., Ltd.
Phase 1/2 Recruiting
NCT05920408 2023-11-08
Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours
Exscientia AI Limited
Phase 1/2 Terminated
NCT05537051 2023-02-08
A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours
Biotheus Inc.
Phase 1 Unknown
NCT02588105 2022-09-19
AToM
AstraZeneca
Phase 1 Completed
NCT04959266 2022-09-16
A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib
AstraZeneca
Phase 1 Terminated
NCT04949425 2022-09-02
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Terminated
NCT04742036 2022-08-19
Capivasertib China PK Study
AstraZeneca
Phase 1 Completed
NCT04462952 2022-07-25
Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT05154604 2021-12-13
A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT03150368 2021-10-19
Extended Use of ModraDoc006/r
Modra Pharmaceuticals
Phase 1 Completed
NCT02430311 2019-07-31
The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.
AstraZeneca
Phase 1 Completed
NCT02341456 2019-03-25
Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours
AstraZeneca
Phase 1 Completed
NCT01252095 2017-10-09
Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours
Zucero Pty Ltd
Phase 1 Terminated
NCT02042781 2017-10-09
Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours
Zucero Pty Ltd
Phase 1 Completed
NCT01581060 2014-05-16
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
Heidelberg Pharma AG
Phase 1/2 Terminated
NCT01859351 2014-05-16
Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours
Heidelberg Pharma AG
Phase 1 Terminated